Results 101 to 110 of about 2,034 (179)

Regulatory roles of NAMPT and NAD+ metabolism in uterine leiomyoma progression: Implications for ECM accumulation, stemness, and microenvironment

open access: yesRedox Biology
Uterine leiomyoma (UL), commonly referred to as benign tumors, is characterized by excessive cell proliferation, extracellular matrix (ECM) accumulation, and the presence of stem cell-like properties.
Yi-Fen Chiang   +7 more
doaj   +1 more source

Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cells

open access: yesEMBO Molecular Medicine, 2012
PARP inhibitors have been proposed as a potential targeted therapy for patients with triple‐negative (ER‐, PR‐, HER2‐negative) breast cancers. However, it is as yet unclear as to whether single agent or combination therapy using PARP inhibitors would be ...
Ilirjana Bajrami   +6 more
doaj   +1 more source

Supplemental Figure S3 from On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells

open access: yes, 2014
Figure S3: Cells were treated for one, two or three days with FK866 at 1 nM, 10 nM and 50 nM. A) AMPK was phosphorylated at all concentrations at day 1, but only at 1 nM after three days incubation with FK866. B) mTOR was phosphorylated at 1 nM and 10 nM
Spencer B. Gibson (10713717)   +6 more
core   +1 more source

Enhancing the anticancer effect of NAMPT inhibition by targeting NAPRT in breast cancer cells

open access: yesAdvances in Cancer Biology - Metastasis
Introduction: Two pathways in the synthesis of NAD, catalyzed by the key enzymes nicotinamide phosphoribosyltransferase (NAMPT) and nicotinate phosphoribosyltransferase (NAPRT), support constant survival, growth, and propagation of cancer cells.
Zahra Gharedaghi   +6 more
doaj   +1 more source

Effects of FK866 and EX527 on p53 acetylation and cell viability in HepG2 cells.

open access: yes, 2014
Cells were stimulated with FK866 [10 nM] or EX527+TSA [20 µM EX527+1 µM TSA] in serum-free medium (con). Cells treated with A) FK866 and expression of acetylated p53 (K382) after 24 h.
Wieland Kiess (102793)   +7 more
core   +1 more source

A549 clonal cell population sensitivity to FK866 (5 nM) before and after IDO induction.

open access: yes, 2015
Proliferation of each of 5 individual A549 cell clonal populations before (Panel A) and after (Panel B) IDO induction with IFNγ. A549 clonal cell populations were cultured with or without IFNγ (25 ng/ml) for 48 h.
Di Chen (15424)   +10 more
core   +1 more source

P100 | Enhanced nad⁺ biosynthesis and ppp activation drive venetoclax resistance in multiple myeloma: therapeutic reversal by nampt inhibition

open access: yesHaematologica
Introduction. Multiple myeloma (MM) is an incurable hematologic malignancy characterized by progressive metabolic reprogramming that accompanies disease evolution. During relapse, MM cells frequently acquire drug resistance, underscoring the need for new
Isabella Traverso
doaj  

Nampt inhibitor FK866 reduced cell survival rate and the NAD level in a dose-dependent manner in SW480 and LoVo cell lines.

open access: yes, 2013
A. Cells were treated with different concentrations of FK866 for 72 h and then evaluated by using Cell Counting Kit-8. The IC50 values were calculated. Each assay was repeated at least 3 times. B.
Jinlu Tong (438902)   +2 more
core   +1 more source

Nam and Na prevent NAD+ shortage and cell death induced by FK866 in human T lymphocytes.

open access: yes, 2013
A, PHA-stimulated PBLs were treated (or not) with 33 nM FK866 in the presence or absence of 10 mM Nam or of 10 µM Na. After 48 h, NAD+ content was determined (expressed as percentage of NAD+ content in FK866-untreated cells). B, PBLs were cultured for 24
Eva Moran (212204)   +18 more
core   +1 more source

Assessment of SWI/SNF chromatin remodeling complex related genes as potential biomarkers and therapeutic targets in pan-cancer

open access: yesMolecular Cancer
Recent research has uncovered a surprisingly high occurrence of aberrant expression and mutations in the genes that encode subunits of the SWI/SNF chromatin-remodeling complexes (SCRC).
Kai Zhuang   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy